• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓增殖性疾病相关的t(8;13)易位融合产物FIM-FGFR1的特征分析

Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation.

作者信息

Ollendorff V, Guasch G, Isnardon D, Galindo R, Birnbaum D, Pébusque M J

机构信息

Laboratoire d'Oncologie Moléculaire, U119 INSERM, Institut de Cancérologie et d'Immunologie, 27 Boulevard Leï Roure, 13009 Marseille, France.

出版信息

J Biol Chem. 1999 Sep 17;274(38):26922-30. doi: 10.1074/jbc.274.38.26922.

DOI:10.1074/jbc.274.38.26922
PMID:10480903
Abstract

The t(8;13) translocation found in a rare type of stem cell myeloproliferative disorder generates a constitutively activated tyrosine kinase containing N-terminal sequence encoded by the FIM gene linked to the FGFR1 kinase domain. Here we have further characterized FIM and FIM-FGFR1 proteins. Firstly, we have studied their respective subcellular localization. We show that FIM has nuclear and nucleolar localization, whereas FIM-FGFR1 is mainly cytoplasmic. Within the nucleolus, FIM colocalizes with the upstream binding factor in interphasic cells, indicating that FIM may be involved in the regulation of rRNA transcription. We demonstrate that the targetting of FIM to the nucleus depends upon its C-terminal region, which is absent in the cytoplasmic FIM-FGFR1 protein. Secondly, we demonstrate that FIM-FGFR1 has constitutive dimerization capability mediated by the FIM N-terminal sequences. Finally, we show that FIM-FGFR1 promotes survival of pro-B Ba/F3 cells after interleukin-3 withdrawal, whereas ligand-activated FGFR1 induced not only cell survival but also interleukin-3 independence. Taken together, these results indicate that FIM-FGFR1 is activated by dimerization as a cytoplasmic kinase and suggest that FIM-FGFR1 partially signals through the FGFR1 pathways.

摘要

在一种罕见类型的干细胞骨髓增殖性疾病中发现的t(8;13)易位产生了一种组成型激活的酪氨酸激酶,该激酶包含由与FGFR1激酶结构域相连的FIM基因编码的N端序列。在此,我们进一步对FIM和FIM-FGFR1蛋白进行了表征。首先,我们研究了它们各自的亚细胞定位。我们发现FIM定位于细胞核和核仁,而FIM-FGFR1主要位于细胞质。在核仁内,FIM在间期细胞中与上游结合因子共定位,这表明FIM可能参与rRNA转录的调控。我们证明FIM靶向细胞核取决于其C端区域,而细胞质中的FIM-FGFR1蛋白缺乏该区域。其次,我们证明FIM-FGFR1具有由FIM N端序列介导的组成型二聚化能力。最后,我们表明FIM-FGFR1在白细胞介素-3撤除后促进前B细胞Ba/F3的存活,而配体激活的FGFR1不仅诱导细胞存活,还诱导白细胞介素-3非依赖性。综上所述,这些结果表明FIM-FGFR1作为一种细胞质激酶通过二聚化被激活,并提示FIM-FGFR1部分通过FGFR1途径发出信号。

相似文献

1
Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation.骨髓增殖性疾病相关的t(8;13)易位融合产物FIM-FGFR1的特征分析
J Biol Chem. 1999 Sep 17;274(38):26922-30. doi: 10.1074/jbc.274.38.26922.
2
8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.8p12干细胞骨髓增殖性疾病:t(6;8)易位产生的FOP-成纤维细胞生长因子受体1融合蛋白通过丝裂原活化蛋白激酶和磷脂酰肌醇3-激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白信号通路介导细胞存活。
Mol Cell Biol. 2001 Dec;21(23):8129-42. doi: 10.1128/MCB.21.23.8129-8142.2001.
3
Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13).在伴有t(8;13)的干细胞增殖性疾病中,成纤维细胞生长因子受体1与FIM融合。
Proc Natl Acad Sci U S A. 1998 May 12;95(10):5712-7. doi: 10.1073/pnas.95.10.5712.
4
The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.与一种非典型骨髓增殖性疾病相关的t(8;13)(p11;q11 - 12)重排,将成纤维细胞生长因子受体1基因与一个新基因RAMP融合。
Hum Mol Genet. 1998 Apr;7(4):637-42. doi: 10.1093/hmg/7.4.637.
5
Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3).在伴有t(8;19)(p12;q13.3)的8p12干细胞骨髓增殖性疾病中,内源性逆转录病毒序列与FGFR1激酶融合。
Blood. 2003 Jan 1;101(1):286-8. doi: 10.1182/blood-2002-02-0577. Epub 2002 Jun 28.
6
Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.在一种骨髓增殖性疾病中,由于t(8;22)(p11;q11)导致的BCR与成纤维细胞生长因子受体1(FGFR1)基因融合:首个涉及BCR但不涉及ABL的融合基因。
Genes Chromosomes Cancer. 2001 Dec;32(4):302-10. doi: 10.1002/gcc.1195.
7
[FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].[FGFR1和MOZ,两个与8p11 - 12染色体区域重排相关的恶性血液病关键基因]
Bull Cancer. 2000 Dec;87(12):887-94.
8
FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.在t(8;13)白血病/淋巴瘤综合征中,成纤维细胞生长因子受体1(FGFR1)与一种新的锌指基因ZNF198发生融合。
Nat Genet. 1998 Jan;18(1):84-7. doi: 10.1038/ng0198-84.
9
Negative regulation of hematopoiesis by the fused in myeloproliferative disorders gene product.
Biochem Biophys Res Commun. 2004 Jan 2;313(1):125-8. doi: 10.1016/j.bbrc.2003.11.097.
10
The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): a novel translocation involving the FGFR1 gene.
Br J Haematol. 2000 Nov;111(2):647-9. doi: 10.1046/j.1365-2141.2000.02355.x.

引用本文的文献

1
Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.转录核心抑制因子 ZMYM2 的突变导致综合征性泌尿道畸形。
Am J Hum Genet. 2020 Oct 1;107(4):727-742. doi: 10.1016/j.ajhg.2020.08.013. Epub 2020 Sep 4.
2
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.全基因组单倍型关联研究确定FGFR2基因为急性髓系白血病的风险基因。
Oncotarget. 2017 Jan 31;8(5):7891-7899. doi: 10.18632/oncotarget.13631.
3
Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case.
伴有t(8;19)(p12;q13.1)及成纤维细胞生长因子受体1(FGFR1)异常的系统性肥大细胞增多症合并相关骨髓增殖性肿瘤:1例独特病例报告
Int J Clin Exp Pathol. 2014 Jan 15;7(2):801-7. eCollection 2014.
4
Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases.Src 激活在 FGFR1 融合激酶诱导的淋巴瘤发生中起着重要关键作用。
Cancer Res. 2011 Dec 1;71(23):7312-22. doi: 10.1158/0008-5472.CAN-11-1109. Epub 2011 Sep 21.
5
Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.ZMYM2-FGFR1 诱导的小鼠 T 细胞淋巴瘤中组成性 Notch 通路激活与非典型骨髓增生性疾病相关。
Blood. 2011 Jun 23;117(25):6837-47. doi: 10.1182/blood-2010-07-295725. Epub 2011 Apr 28.
6
Targeting mutant fibroblast growth factor receptors in cancer.针对癌症中的突变型成纤维细胞生长因子受体。
Trends Mol Med. 2011 May;17(5):283-92. doi: 10.1016/j.molmed.2011.01.012. Epub 2011 Mar 1.
7
Phosphorylation of the SSBP2 and ABL proteins by the ZNF198-FGFR1 fusion kinase seen in atypical myeloproliferative disorders as revealed by phosphopeptide-specific MS.磷酸肽特异性质谱分析显示,在非典型骨髓增殖性疾病中可见ZNF198 - FGFR1融合激酶对SSBP2和ABL蛋白进行磷酸化。
Proteomics. 2009 Aug;9(16):3979-88. doi: 10.1002/pmic.200800852.
8
Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1.骨髓增殖性肿瘤中的分子药物靶点:突变型ABL1、JAK2、MPL、KIT、PDGFRA、PDGFRB和FGFR1。
J Cell Mol Med. 2009 Feb;13(2):215-37. doi: 10.1111/j.1582-4934.2008.00559.x. Epub 2008 Oct 23.
9
The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report.8p11骨髓增殖综合征:文献综述及一例病例报告
Int J Clin Exp Pathol. 2008 Jan 1;1(5):448-56.
10
14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.14-3-3在ZNF198-FGFR1转化的造血细胞中整合由AKT和MAPK途径介导的促生存信号。
Blood. 2007 Jul 1;110(1):360-9. doi: 10.1182/blood-2006-12-065615. Epub 2007 Mar 27.